Trademarkia Logo

Canada

C$
APROGEN
FORMALIZED

on 2 Jun 2022

Last Applicant/ Owned by

APROGEN INC.

B1F, 545, Dunchon-daeroJungwon-gu, Seongnam-siGyeonggi-do, 13215,

KR

Serial Number

2189683 filed on 2th Jun 2022

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

APROGEN

Trademark usage description

pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of diabetes; pharmaceutical pre Read More

Classification Information


Class [001]
Chemicals and adhesives


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for Immunomodulation; pharmaceutical preparations for immune-enhancing; pharmaceutical preparations for intestinal health and for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; medicines for the treatment of cardiovascular and cerebrovascular diseases; medicines for treating intestinal disorders; medicines for the treatment of gastrointestinal diseases; vaccines for human use; influenza vaccines; vaccines against pneumococcal infections; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; biochemicals in the form of monoclonal antibodies for research use; colostral antibodies for medical purposes; antibody therapeutic preparations for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of acute respiratory distress syndrome (ARDS); antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune diseases


Classification kind code

11

Mark Details


Serial Number

2189683

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 25th Jul 2024
Agent Changed
Submitted for opposition 135
on 14th Oct 2022
Amendment to Application
Submitted for opposition 287
on 20th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 2th Jun 2022
Filed
Submitted for opposition 1
on 2th Jun 2022
Created
Submitted for opposition 31
on 2th Jun 2022
Formalized